Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Memphasys Ltd (AU:MEM)
ASX:MEM
Holding AU:MEM?
Track your performance easily
MEM Stock Chart & Stats
Day’s RangeAU$0 - AU$0
52-Week Range<AU$0.01 - AU$0.01
Previous CloseAU$0.01
Volume686.67K
Average Volume (3M)1.08M
Market Cap
AU$9.70M
Enterprise ValueAU$14.99M
Total Cash (Recent Filing)AU$269.08K
Total Debt (Recent Filing)AU$5.56M
Price to Earnings (P/E)―
Beta-0.87
Next Earnings
Feb 21, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares OutstandingN/A
10 Day Avg. Volume2,824,262
30 Day Avg. Volume1,082,286
Standard Deviation0.21
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)972.50
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Memphasys Ltd News
PremiumCompany Announcements
Memphasys Ltd Reports Positive AGM Outcomes
PremiumCompany Announcements
Memphasys Limited Eyes Growth in Reproductive Biotechnology
PremiumCompany Announcements
Memphasys Appoints New Chair Amid Key Developments
PremiumCompany Announcements
Memphasys Nears Completion of Key Trial for Felix™ SystemPremiumCompany Announcements
Memphasys Ltd Issues New Unquoted Loan Options
PremiumCompany Announcements
Memphasys Ltd Expands with New ASX Securities Issuance
PremiumCompany Announcements
Memphasys Bolsters Financial Position with $1.857M Capital Raise
PremiumCompany Announcements
Memphasys Limited Expands Market with Innovative ART SolutionsMEM FAQ
What was Memphasys Ltd’s price range in the past 12 months?
Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.
What is Memphasys Ltd’s market cap?
Currently, no data Available
When is Memphasys Ltd’s upcoming earnings report date?
Memphasys Ltd’s upcoming earnings report date is Feb 21, 2025 which is in 91 days.
How were Memphasys Ltd’s earnings last quarter?
Memphasys Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.
Is Memphasys Ltd overvalued?
According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued.
Does Memphasys Ltd pay dividends?
Memphasys Ltd does not currently pay dividends.
What is Memphasys Ltd’s EPS estimate?
Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Memphasys Ltd have?
Memphasys Ltd has 1,763,081,400 shares outstanding.
What happened to Memphasys Ltd’s price movement after its last earnings report?
Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Memphasys Ltd?
Currently, no hedge funds are holding shares in AU:MEM
---
Memphasys Ltd Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:MEM Sentiment 100%
Sector Average 72%
Sector Average 72%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
-62.46%
Trailing 12-Months
Asset Growth
-15.26%
Trailing 12-Months
Company Description
Memphasys Ltd
Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.
---
Race Oncology Ltd.
―
LBT Innovations Limited
―
PainChek Ltd
―
Avecho Biotechnology Limited
―
---